Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - August 2001

  1. CDC expands influenza vaccination window, acknowledges supply problems Am.J.Health Syst.Pharm. 6-15-2001, 58 (12): 1076-1077.

  2. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999 MMWR Morb.Mortal.Wkly.Rep. 6-29-2001, 50 (25): 532-537. Keywords: Aged/Female/Human/Influenza/prevention & control/Influenza Vaccine/administration & dosage/Male/Pneumococcal Infections/Pneumococcal Vaccines/United States/Vaccination/utilization

  3. From the Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged >/= 65 years--United States, 1999 JAMA. 7-25-2001, 286 (4): 413-414.

  4. From the Centers for Disease Control and Prevention. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000 JAMA. 7-25-2001, 286 (4): 411-413.

  5. Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care CMAJ. 6-26-2001, 164 (13): 1888-1889.

  6. Artz, A. S. and Ershler, W. B. Pneumococcal vaccination in adults JAMA. 7-11-2001, 286 (2): 166-167.Keywords: Adult/Human/Pneumococcal Infections / epidemiology / prevention & control/Pneumococcal Vaccines/administration & dosage/Vaccination

  7. Bahta, L. M., Wexler, D. L., and Atkinson, W. L. A screening questionnaire for contraindications to vaccination Pediatr.Ann. 2001, 30 (7): 418-421.

  8. Borrow, R., Goldblatt, D., Andrews, N., Richmond, P., Southern, J., and Miller, E. Influence of prior meningococcal c polysaccharide vaccination on the response and generation of memory after meningococcal c conjugate vaccination in young children J.Infect.Dis. 8-1-2001, 184 (3): 377-380.

  9. Brouns, R., Verlinde, P., Lagae, L., De Koster, J., Lemmens, F., and Van de, Casseye W. Subacute sclerosing panencephalitis in a vaccinated, internationally adopted child Acta Neurol.Belg. 2001, 101 (2): 128-130.

  10. Campos, J. Haemophilus influenzae: from the post-vaccination era to antibiotic resistance Clin.Microbiol.Infect. 2001, 7 (6): 287-290.

  11. Ceyhan, M., Kanra, G., Erdem, G., and Kanra, B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age Vaccine. 8-14-2001, 19 (31): 4473-4478.

  12. Dayan, G. H., Nguyen, V. H., Debbag, R., Gomez, R., and Wood, S. C. Cost-effectiveness of influenza vaccination in high-risk children in Argentina Vaccine. 2001, %20;19 (30): 4204-4213.

  13. Egemen, A., Aksit, S., Ozacar, T., Kurugol, Z., Keskinoglu, P., Pehlivan, T., and Mutlu, S. Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey Pediatr.Int. 2001, 43 (4): 379-384.

  14. Hall, G. H. Antiflu, or antideath vaccination? Lancet. 6-30-2001, 357 (9274): 2141.

  15. Keiholz, U., Scheibenbogen, C., Theil, E., and Schadendorf, D. Rational development of peptide vaccination in clinical oncology Onkologie. 2001, 24 (2): 174.

  16. Kovarik, J. and Siegrist, C. A. The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way? Arch.Immunol.Ther.Exp.(Warsz.). 2001, 49 (3): 209-215.

  17. Kyaw, M. H., Bramley, J. C., Chalmers, J., Jones, I. G., and Campbell, H. Pneumococcal vaccination: opinion of general practitioners and hospital doctors in Scotland, 1999-2000 Commun.Dis.Public Health. 2001, 4 (1): 42-48.

  18. Lopez, J. A., Weilenman, C., Audran, R., Roggero, M. A., Bonelo, A., Tiercy, J. M., Spertini, F., and Corradin, G. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies Eur.J.Immunol. 2001, 31 (7): 1989-1998.

  19. Marianneau, P., Georges-Courbot, M., and Deubel, V. Rarity of adverse effects after 17D yellow-fever vaccination Lancet. 7-14-2001, 358 (9276): 84-85.

  20. Martin, M., Tsai, T. F., Cropp, B., Chang, G. J., Holmes, D. A., Tseng, J., Shieh, W., Zaki, S. R., Al Sanouri, I., Cutrona, A. F., Ray, G., Weld, L. H., and Cetron, M. S. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases Lancet. 7-14-2001, 358 (9276): 98-104.

  21. Martin, S., Sadler, F., Borrow, R., Dawson, M., Fox, A., and Cartwright, K. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine Vaccine. 8-14-2001, 19 (31): 4404-4408.

  22. McCormick, A., Dinakaran, S., Bhola, R., and Rennie, I. G. Recurrent sixth nerve palsy following measles mumps rubella vaccination Eye. 2001, 15 (Pt 3): 356-357.

  23. Mooi, F. R., van Loo, I. H., and King, A. J. Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence? Emerg.Infect.Dis. 2001, 7 (3 Suppl): 526-528.

  24. Moreno, S., Blazquez, R., Novoa, A., Carpena, I., Menasalvas, A., Ramirez, C., and Guerrero, C. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees Arch.Intern.Med. 7-23-2001, 161 (14): 1760-1765.

  25. Ryan, E. J., Daly, L. M., and Mills, K. H. Immunomodulators and delivery systems for vaccination by mucosal routes Trends Biotechnol. 2001, 19 (8): 293-304.

  26. Sinisalo, M., Aittoniemi, J., Oivanen, P., Kayhty, H., Olander, R. M., and Vilpo, J. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia Br.J.Haematol. 2001, 114 (1): 107-110.

  27. Skull, S. A., Andrews, R. M., Gorrie, G. J., Riddell, M. A., and Street, A. C. Healthcare workers continue to be at risk of measles: a case for better vaccination coverage Med.J.Aust. 6-18-2001, 174 (12): 662-663.

  28. Skull, S. A. and Wang, E. E. Varicella vaccination-a critical review of the evidence Arch.Dis.Child. 2001, 85 (2): 83-90.

  29. Tunstall-Pedoe, S. The role of opportunistic vaccination should not be forgotten Fam.Pract. 2001, 18 (4): 464.

  30. Vessey, S. J., Chan, C. Y., Kuter, B. J., Kaplan, K. M., Waters, M., Kutzler, D. P., Carfagno, P. A., Sadoff, J. C., Heyse, J. F., Matthews, H., Li, S., and Chan, I. S. Childhood vaccination against varicella: Persistence of antibody, duration of protection, and vaccine efficacy J.Pediatr. 2001, 139 (2): 297-304.

Back to Top